CXCL10/IP-10/CRG-2 Protein 266-IP-010/CF from R&D Systems, a Bio-Techne Brand

Product Specs
ItemCXCL10/IP-10/CRG-2 Protein
CompanyR&D Systems, a Bio-Techne Brand
Price $155.00Supplier Page View Company Product Page
Catalog Number266-IP-010/CF
SpeciesHuman
Molecule NameCXCL10/IP-10/CRG-2
Size10 ug (also 50 ug)
FormatLyophilized from a 0.2 µm filtered solution in PBS
NCBI Full Gene NameC-X-C motif chemokine ligand 10
NCBI Gene AliasesgIP-10, INP10, IP-10, mob-1, IFI10, crg-2, C7, SCYB10
Purity>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
ApplicationsBioactivity
Conjugate/TagUnconjugated
Source/Expression SystemE. coli-derived Recombinant Human CXCL10/IP-10 Protein, CF
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

Specifications/Features

Available conjugates: Sizes Available: 10 ug (also 50 ug)

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) The adult nasal mucosa is defined by distinct immune profiles that modulate in-vitro SARS-CoV-2 infectionResearch SquareJanuary 29, 2026Sarah N Gowanlock, Victor HK Lam, Zeynep Güneş Tepe, Daniel E Park, Vera Tai, Juan E Salazar, Tony Pham, Yazan Khan, Sydney Nelson, Caitlin Horn, et al.ng/mL; 278-RN-010/CF, R&D Systems), TNF-α (50 ng/mL; 210-TA-020/CF, R&D Systems), IP-10 (400 ng/mL; 266-IP-010/CF, R&D Systems), IL-8 (200 ng/mL; 208-IL-010/CF, R&D Systems), and MIG (400 ng/mL; 392-MG-010/CF, R&D Systems

(2) Tissue CD14(+)CD8(+) T cells reprogrammed by myeloid cells and modulated by LPSNatureFebruary 1, 2023Pallett LJ, Swadling L, Diniz M, Maini AA, Schwabenland M, Gasull AD, Davies J, Kucykowicz S, Skelton JK, Thomas N, et al.

(3) Ultra-Sensitive and Semi-Quantitative Vertical Flow Assay for the Rapid Detection of Interleukin-6 in Inflammatory DiseasesBiosensorsSeptember 14, 2022Lei R, Arain H, Obaid M, Sabhnani N, Mohan C.

(4) Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinibJCI insightAugust 22, 2022Rijvers L, van Langelaar J, Bogers L, Melief MJ, Koetzier SC, Blok KM, Wierenga-Wolf AF, de Vries HE, Rip J, Corneth OB, et al.

(5) Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapyNature communicationsApril 12, 2022Kim ST, Chu Y, Misoi M, Suarez-Almazor ME, Tayar JH, Lu H, Buni M, Kramer J, Rodriguez E, Hussain Z, et al.

(6) Chemoattraction of Neoplastic Glial Cells with CXCL10, CCL2 and CCL11 as a Paradigm for a Promising Therapeutic Approach for Primary Brain TumorsInternational journal of molecular sciencesNovember 10, 2021Déry L, Charest G, Guérin B, Akbari M, Fortin D.

(7) Role of CXCL10 in the progression of in situ to invasive carcinoma of the breastScientific reportsSeptember 9, 2021Kim M, Choi HY, Woo JW, Chung YR, Park SY.

(8) Immune-Stimulatory Effects of Curcumin on the Tumor Microenvironment in Head and Neck Squamous Cell CarcinomaCancersMarch 16, 2021Kötting C, Hofmann L, Lotfi R, Engelhardt D, Laban S, Schuler PJ, Hoffmann TK, Brunner C, Theodoraki MN.

(9) Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronavirusesPloS oneJanuary 1, 2021Ravindran R, McReynolds C, Yang J, Hammock BD, Ikram A, Ali A, Bashir A, Zohra T, Chang WLW, Hartigan-O'Connor DJ, et al.

(10) CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune responseProceedings of the National Academy of Sciences of the United States of AmericaNovember 17, 2020Biasci D, Smoragiewicz M, Connell CM, Wang Z, Gao Y, Thaventhiran JED, Basu B, Magiera L, Johnson TI, Bax L, et al.

(11) Mitochondrial mass governs the extent of human T cell senescenceAging cellFebruary 1, 2020Callender LA, Carroll EC, Bober EA, Akbar AN, Solito E, Henson SM.

(12) CXCR4, but not CXCR3, drives CD8⁺ T-cell entry into and migration through the murine bone marrowEuropean journal of immunologyApril 1, 2019Goedhart M, Gessel S, van der Voort R, Slot E, Lucas B, Gielen E, Hoogenboezem M, Rademakers T, Geerman S, van Buul JD, et al.

(13) Upregulation of chemokine CXCL10 enhances chronic pulmonary inflammation in tree shrew collagen-induced arthritisScientific reportsJuly 3, 2018Gao B, Lin J, Jiang Z, Yang Z, Yu H, Ding L, Yu M, Cui Q, Dunavin N, Zhang M, et al.

(14) Neuregulin-1 attenuates experimental cerebral malaria (ECM) pathogenesis by regulating ErbB4/AKT/STAT3 signalingJournal of neuroinflammationApril 10, 2018Liu M, Solomon W, Cespedes JC, Wilson NO, Ford B, Stiles JK.

(15) Effect of a Combination of Prednisone or Mycophenolate Mofetil and Mesenchymal Stem Cells on Lupus Symptoms in MRL.Fas^lpr MiceStem cells internationalJanuary 1, 2018Lee HK, Kim KH, Kim HS, Kim JS, Lee JH, Ji A, Kim KS, Lee TY, Chang IY, Bae SC, et al.

(16) Serum level of CXCL10 is associated with inflammatory prognostic biomarkers in patients with diffuse large B-cell lymphomaHematological oncologyDecember 1, 2017Hong JY, Ryu KJ, Lee JY, Park C, Ko YH, Kim WS, Kim SJ.

(17) Protein profiling identified key chemokines that regulate the maintenance of human pluripotent stem cellsScientific reportsNovember 6, 2017Jiang Z, Li Y, Ji X, Tang Y, Yu H, Ding L, Yu M, Cui Q, Zhang M, Ma Y, et al.

(18) Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetesJCI insightJuly 6, 2017Schludi B, Moin ASM, Montemurro C, Gurlo T, Matveyenko AV, Kirakossian D, Dawson DW, Dry SM, Butler PC, Butler AE.

(19) Induction of cathepsin B by the CXCR3 chemokines CXCL9 and CXCL10 in human breast cancer cellsOncology lettersJune 1, 2017Bronger H, Karge A, Dreyer T, Zech D, Kraeft S, Avril S, Kiechle M, Schmitt M.

(20) Engineering the haemogenic niche mitigates endogenous inhibitory signals and controls pluripotent stem cell-derived blood emergenceNature communicationsMay 25, 2017Rahman N, Brauer PM, Ho L, Usenko T, Tewary M, Zúñiga-Pflücker JC, Zandstra PW.

Be the First to Write a Review!

Recombinant Human CXCL10/IP-10 Protein, CF

CXCL10/IP-10/CRG-2 Protein

CXCL10/IP-10/CRG-2 Protein

CXCL10/IP-10/CRG-2 Protein

CXCL10/IP-10/CRG-2 Protein from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (54)

Reviews

CXCL10/IP-10/CRG-2 Protein from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map